trending Market Intelligence /marketintelligence/en/news-insights/trending/uxi4zqohrrstp-b-iixgra2 content esgSubNav
In This List

Factor Therapeutics director retires

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Factor Therapeutics director retires

Factor Therapeutics Ltd. said Robert Ryan retired from the board.

Ryan joined the board as a nonexecutive director in September 2016. He is president and CEO of Innova Therapeutics.

Darra, Australia-based Factor Therapeutics is a clinical-stage biotechnology company that develops and commercializes treatments for wound care and healing.